Scientists have discovered a powerful gene-targeting system in viruses. Billions of years old, VIPR seems to predate CRISPR and may be even more effective.
Over the past decade, the gene-editing ...
...Now, a new frontier in biotechnology aims to harness this natural mechanism to do something once thought impossible: scrub away the biological detritus of our own past. By mimicking ...
Shares of Scribe Therapeutics, a genetic-medicines company co-founded by Nobel laureate Jennifer Doudna, shot up on their first day of trading Friday, continuing a rebound for biotech IPOs this year.
Scribe sold ...
The inventor of the groundbreaking Crispr gene-editing technology is skeptical about artificial intelligence replacing human effort in the realm of scientific discovery, adding to a growing debate over its ...
For months, the researchers trying to save KJ Muldoon knew him only as ‘Patient Eta’.
He was born in August 2024 with CPS1 deficiency, an ultra‐ rare urea‐cycle disorder that ...
Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer Jennifer Doudna wants to build an entire ecosystem to bring ...
From decoding the human genome to exploring the universe, science has made huge strides in the 21st century.
While the 21st century has been bumpy, it has also ushered in ...
This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.
For a decade after its discovery, CRISPR gene editing was stuck on ...
Jennifer Doudna on CRISPR's Next Frontier: From Rare Disease Breakthroughs to Agricultural Innovation
Nobel Laureate discusses groundbreaking baby KJ case, sickle cell progress, and the future of gene editing at ...
New Center Aims to Scale Personalized CRISPR Cures for Children with Rare Genetic Diseases
Bloomberg covers the launch of the Center for Pediatric CRISPR Cures - a $20M initiative that ...
...Tweaking proteins to do human bidding is nothing new. Enzymes and antibodies, for example, have long endured such outrages. But that is not what Dr Ennist is up to. ...
During a visit to Lawrence Berkeley National Laboratory (Berkeley Lab), Secretary of Energy Chris Wright today announced a new contract with Dell Technologies to develop NERSC-10, the next flagship ...
The technique used on a 9½-month-old boy with a rare condition has the potential to help people with thousands of other uncommon genetic diseases.
Something was very wrong with Kyle ...
In early 2005 Rodolphe Barrangou and Philippe Horvath were staring at some very odd bits of repeating genetic code on a computer screen in France. The sequences came from ...
The genome-editing technology can be supercharged by artificial intelligence—and the results are already being felt.
In 2025, we will see AI and machine learning begin to amplify the impact of Crispr genome ...
The technology’s promise can sound like science fiction—it might help us adapt to a radically different climate, or grow organs for people in need—but experts are also concerned about ...
Four years ago, Jennifer Doudna and Emmanuelle Charpentier shared the Nobel Prize in chemistry for the development of a method for genome editing called CRISPR-Cas9.
In her lecture, Doudna detailed “extraordinary and exciting opportunities” for the technology ...
How do we develop and integrate breakthrough health technology into our lives?
From robot helpers to smart prosthetics to "smart skin" to CRISPR gene editing, our ability to build a ...
Prof Jennifer Doudna, the ‘Godmother of Crispr’, says ‘figuring out how to edit the brain is probably coming in the next decade’.
Jennifer Doudna says she is an “unlikely success ...
Why Jennifer Doudna is one of Fast Company’s 10 most innovative people of the last 10 years
Doudna codeveloped the revolutionary gene-editing technology known as CRISPR-Cas9. Now it’s leading to ...
"Reengineering Life: The Next Frontiers in Science" is Fareed Zakaria GPS's special report on CNN profiling Nobel Laureate and Innovative Genomics Institute founder Jennifer Doudna and the development, rise, ...
If the first CRISPR decade was marked by a mad dash to evolve, engineer, and mine the bacterial universe for more and better genome-editing enzymes, so far the second seems ...
New advancements in artificial intelligence have the capacity to deliver major breakthroughs in cancer therapy.
AI-powered protein design company Profluent used AI to make an open-source gene editor called OpenCRISPR-1.
OpenCRISPR-1 ...
Late blight is an old foe of humans. This disease catalysed the devastating Irish potato famine that began in 1845.
It is caused by a fungus-like pathogen, which quickly kills ...
For stretched public health budgets, high-tech treatments are hard to afford but some pre-emptive measures can prove good value.
As hay fever season arrives, once again, for allergy and asthma ...
Much as ChatGPT generates poetry, a new A.I. system devises blueprints for microscopic mechanisms that can edit your DNA.
Generative A.I. technologies can write poetry and computer programs or create images of teddy ...
Funding propels company’s proprietary platform consisting of Generative AI models and large-scale datasets purpose-built for designing and validating novel proteins, opening new frontiers in therapeutics and industrial applications
...
Expanding medical therapies based on Crispr gene-editing globally is “unrealistic” and the sector needs heavy investment to make the technology, which could transform treatment of diseases, accessible to all, ...
Around 10 million. That’s the number of lives forecasters believe we will lose each year by 2050 as bacteria develop defenses against the drugs we use to fight infections.
Tackling antibiotic resistance, though, ...
In his January 20, 2024 TEDxBerkeley Talk, Dr. Benjamin Oakes delves into the profound potential of CRISPR technology and its ability to transform healthcare.
Dr. Oakes is co-founder and ...
The Beacon for CRISPR Cures aims to create a roadmap for rapidly developing genome-editing therapies.
The story of CRISPR in medicine so far has been one of remarkable speed. It ...
Crispr recently marked a major milestone in medicine. But it's not time for a victory lap—the race is just beginning.
By Jennifer Doudna, CRISPR pioneer and Nobel Laureate at the ...
Editing DNA with the same ease as spell-checking a Word document is a scientific holy grail. It would allow debilitating and deadly genetic diseases to not only be treated, ...
In a landmark decision, the Food and Drug Administration Friday approved the first gene-editing treatment to alleviate human illness.
The FDA approved two gene therapies for anyone 12 and older ...
The Food and Drug Administration’s approval on Friday of two groundbreaking gene therapy treatments for sickle cell disease has brought a rare moment of hope and celebration to people with the ...
The gene-editing revolution is jumping from the lab to the marketplace.
The U.S. has approved the world’s first medicine employing Crispr technology, a Nobel Prize-winning discovery that promised a powerful new tool ...
In a major advance, the Food and Drug Administration on Friday approved two gene therapies that target sickle cell disease, one of which is the first commercially available treatment in the United States ...
It was only 11 years ago that scientists Jennifer Doudna and Emmanuelle Charpentier first described a new way to edit genes, called CRISPR, in a scientific paper. The discovery is so game-changing ...
When Victoria Gray was still a baby, she started howling so inconsolably during a bath that she was rushed to the emergency room. The diagnosis was sickle-cell disease, a ...
It usually takes time for scientific discoveries in the lab to make their way to the market.
The groundbreaking gene-editing technology known as Crispr, which acts like a molecular pair ...
